Gene Name: ygaE (BSU08700)
Protein Name: UPF0421 protein YgaE
Sequence: Full-length 353-amino acid protein (UniProt: P71083) with the sequence:
MKLGARIFKTGIAITLALYLASWIGLPAPIFAGIAAIFAIQPSIYRSFLIIIDQVQANIIGAVIATVFGLIFGPSPIMIGLTAVIVITIMLKLKIEHTISIALVTVIAILESAGDDFLMFALIRTSTVILGVLSSFIVNLVFLPPKYETKLIHNTVENTEEIMKWIRLSMRQSTEHSILKEDIEKLKEKMIKLDQTYLLYKEERSYFKKTTYVKSRKLVLFRQAIITANRALDTLKKLHRLENEIYHMPEEFQETLTEELDYLLYWHERILMRFVGKIKPHDDAVEEGIRYKQLLTKSFLKNQQNTDEELIDYNMLNIMASAVEYREQLEHLETLITSFQTYHPKDCEIETEE .
Promoter Engineering: Strong σ<sup>H</sup>-dependent promoters (e.g., P<sub>sdp</sub>) enhance expression 38.3-fold compared to traditional promoters .
Secretion Optimization: Sec and Tat pathways are leveraged for efficient extracellular secretion, supported by chaperones like PrsA .
Strain Engineering: Genome-minimized B. subtilis strains lacking prophages, sporulation genes, and proteases achieve >3,000-fold increases in functional protein yields .
Hypothetical Role: YgaE is implicated in stress response pathways due to its upregulation in protease-deficient strains .
Biotechnological Utility: Serves as a model protein for testing secretion efficiency in B. subtilis .
Proteolytic Degradation: Addressed using B. subtilis WB800 (Δ8 proteases) or BRB strains (Δ10 proteases) .
Low Yield: Resolved via promoter engineering (e.g., P<sub>skfA</sub>-1) and ribosomal binding site optimization .
Folding Limitations: Co-expression of E. coli SecB or staphylococcal DsbA improves disulfide bond formation .
KEGG: bsu:BSU08700
STRING: 224308.Bsubs1_010100004818
UPF0421 protein ygaE is a protein encoded by the ygaE gene in Bacillus subtilis (strain 168). It is classified as part of the UPF0421 protein family and has historically been referred to as "hypothetical protein BSU08700" prior to functional characterization . The full-length protein consists of 353 amino acids with the sequence:
MKLGARIFKTGIAITLALYLASWIGLPAPIFAGIAAIFAIQPSIYRSFLIIIDQVQANIIGAVIATVFGLIFGPSPIMIGLTVIVITILKLKIEHTISIALVTVAILSAGDDFLMFALIRTSTVILGVLSSFIVNLVFLPPKYETKLIHNTVENTEEIMKWIRLSMRQSTEHSILKEDIEKLKEKMIKLDQTYLLYKEERSYFKKTTYVKSRKLVLFRQAIITANRALDTLKKLHRLENEIYHMPEEFQETLTEELDYLLYWHERILMRFVGKIKPHDDAVEEGIRYKQLLTKSFLKNQQNTEEELIDYNMLNIMASAVEYREQLEHLELTITSFQTYHPKDCEIETEE
Based on sequence analysis, the protein contains transmembrane domains and hydrophobic regions, suggesting it may be membrane-associated. The "UPF" designation (Uncharacterized Protein Family) indicates that while the protein has been identified, its precise biological function remains to be fully elucidated through experimental validation.
Several expression systems have proven effective for the recombinant production of UPF0421 protein ygaE, with varying advantages depending on research objectives:
| Expression System | Advantages | Typical Yields | Applications |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid expression | 2-10 mg/L culture | Structural studies, antibody production |
| Yeast | Post-translational modifications, proper folding | 1-5 mg/L culture | Functional studies |
| Baculovirus | Complex eukaryotic processing | 1-8 mg/L culture | Protein-protein interaction studies |
| Mammalian Cell | Native-like modifications | 0.5-2 mg/L culture | Functional characterization |
| Cell-Free Expression | Rapid production, membrane protein compatibility | 0.1-1 mg/reaction | Preliminary studies, toxic protein production |
Each of these systems has been utilized for producing recombinant Bacillus subtilis UPF0421 protein ygaE with at least 85% purity as determined by SDS-PAGE analysis . The selection of an appropriate expression system should be guided by the specific requirements of the intended research application.
Purification of recombinant UPF0421 protein ygaE typically employs affinity chromatography approaches, leveraging tagged versions of the protein. His-tagged variants are commonly used due to their efficient purification profile . A standard purification protocol involves:
Bacterial cell lysis using sonication or mechanical disruption in appropriate buffer conditions
Clarification of lysate by centrifugation (typically 15,000 × g for 30 minutes)
Immobilized metal affinity chromatography (IMAC) using Ni-NTA or similar resin
Washing steps with increasing imidazole concentrations to remove non-specific binding
Elution with high imidazole buffer (250-500 mM)
Buffer exchange via dialysis or size exclusion chromatography
Concentration determination and purity assessment via SDS-PAGE
This approach consistently yields preparations with ≥85% purity suitable for most research applications . For studies requiring higher purity, additional chromatography steps such as ion exchange or hydrophobic interaction chromatography may be incorporated into the workflow.
To maintain the structural integrity and biological activity of purified UPF0421 protein ygaE, specific storage conditions have been empirically determined:
Short-term storage (up to one week): 4°C in Tris-based buffer
Medium-term storage: -20°C in buffer containing 50% glycerol
Long-term storage: -80°C in aliquots to prevent freeze-thaw cycles
Repeated freeze-thaw cycles significantly reduce protein activity and integrity, with each cycle potentially causing 10-30% activity loss. Therefore, working aliquots should be prepared during initial purification to minimize this issue . The addition of protease inhibitors and reducing agents (such as DTT or β-mercaptoethanol) at appropriate concentrations may further enhance stability during storage.
Given the predicted transmembrane domains in UPF0421 protein ygaE, determining its precise membrane topology is crucial for understanding its function. Several complementary approaches can be employed:
Protease accessibility assays: By exposing membrane-embedded protein to proteases from either side of the membrane and analyzing the resulting fragments by mass spectrometry, researchers can identify which regions are exposed versus protected.
Cysteine scanning mutagenesis combined with thiol-reactive labeling: This involves creating a series of single-cysteine mutants throughout the protein sequence and assessing their accessibility to membrane-impermeable thiol-reactive reagents.
Fluorescence resonance energy transfer (FRET): By incorporating donor and acceptor fluorophores at specific positions, the relative distances between protein regions can be measured, providing information about protein folding within the membrane.
Cryo-electron microscopy: For high-resolution structural analysis of the protein in a near-native membrane environment.
Computational prediction validation: Experimental validation of transmembrane domain predictions using algorithms such as TMHMM, Phobius, or HMMTOP through site-directed mutagenesis of predicted critical residues.
These approaches should be used in combination, as each has inherent limitations. The integration of multiple lines of evidence provides the most robust determination of membrane topology.
Determining the function of UPF0421 protein ygaE requires a systematic experimental approach:
Gene knockout/knockdown studies: Create ygaE deletion mutants in Bacillus subtilis and characterize phenotypic changes under various growth conditions. Complementation studies with wild-type protein can confirm specificity of observed phenotypes.
Protein-protein interaction screens:
Bacterial two-hybrid assays
Co-immunoprecipitation followed by mass spectrometry
Proximity labeling techniques (BioID or APEX2 fusion proteins)
Transcriptomic and proteomic profiling: Compare wild-type and ΔygaE strains to identify affected pathways.
Structural analysis: Determine the three-dimensional structure using X-ray crystallography or cryo-EM to identify potential functional domains and binding sites.
Biochemical activity assays: Based on structural insights and homology predictions, design assays to test specific enzymatic activities (e.g., ATPase, GTPase, or transporter function).
Localization studies: Employ fluorescent protein fusions or immunofluorescence to determine subcellular localization, which may provide functional clues.
Evolutionary analysis: Comparative genomics across bacterial species to identify conserved domains and potential functional conservation.
The most effective approach combines multiple methods, with each subsequent experiment building on insights from previous findings.
Recombinant expression of UPF0421 protein ygaE presents several challenges that researchers should anticipate:
For membrane-associated proteins like ygaE, cell-free expression systems have shown particular promise, as they avoid the challenges of membrane insertion during expression while maintaining the ability to produce properly folded protein .
Investigating protein-protein interactions involving UPF0421 protein ygaE requires specialized approaches that account for its potential membrane association:
Membrane-based split-ubiquitin yeast two-hybrid system: This adaptation of the classical two-hybrid system is specifically designed for membrane proteins and can detect interactions in a near-native membrane environment.
In vivo crosslinking followed by mass spectrometry: Chemical crosslinkers can capture transient interactions, which are subsequently identified through proteomic analysis.
Co-purification assays with controlled detergent solubilization: Mild detergents can maintain protein-protein interactions during purification, allowing identification of stable complexes.
Surface plasmon resonance (SPR) with reconstituted proteoliposomes: This provides quantitative binding kinetics between ygaE and potential interaction partners.
Fluorescence-based techniques:
Förster resonance energy transfer (FRET)
Bimolecular fluorescence complementation (BiFC)
Fluorescence correlation spectroscopy (FCS)
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This can map interaction interfaces by identifying regions protected from exchange when complexes form.
When designing these experiments, researchers should include appropriate controls:
Non-specific binding controls (e.g., using unrelated proteins)
Membrane-associated protein controls to distinguish specific from non-specific membrane interactions
Negative controls using mutated binding sites once interaction regions are identified
Computational methods offer valuable insights into potential functions of UPF0421 protein ygaE:
Homology detection using profile-based methods: Tools like HHpred or HMMER can detect remote homology to characterized proteins that might not be identified by standard BLAST searches.
Structural prediction and analysis:
AlphaFold2 for 3D structure prediction
Identification of structural motifs that correspond to known functional domains
Molecular docking to predict potential binding partners or substrates
Genomic context analysis:
Examining operons containing ygaE across bacterial species
Gene neighborhood conservation patterns
Co-evolution networks to identify functionally related proteins
Protein family analysis:
Conservation patterns of specific residues within the UPF0421 family
Identification of signature motifs that may indicate function
Phylogenetic profiling to correlate presence/absence with specific metabolic capabilities
Integration of -omics data:
Analysis of expression correlation networks
Metabolic pathway mapping to identify potential roles
Phenotypic data from genome-wide studies
A comprehensive bioinformatic workflow might begin with sequence analysis, progress to structural prediction, incorporate evolutionary information, and culminate in the development of testable hypotheses regarding protein function.
Site-directed mutagenesis represents a powerful approach for dissecting the structure-function relationship of UPF0421 protein ygaE. An effective experimental design includes:
Target selection based on multiple criteria:
Conserved residues identified through multiple sequence alignments of homologs
Predicted functional motifs or domains from bioinformatic analyses
Charged or polar residues in predicted transmembrane regions (often functionally important)
Residues predicted to participate in substrate binding or catalysis
Mutation strategy:
Conservative substitutions to test the importance of specific chemical properties
Alanine scanning of regions of interest to identify essential residues
Charge reversal mutations to test electrostatic interactions
Introduction of reporter groups (e.g., cysteine residues for labeling studies)
Functional assessment:
Complementation assays in ygaE knockout strains
In vitro activity assays for specific biochemical functions
Localization studies to ensure proper membrane targeting
Stability assessments to distinguish functional vs. structural effects
A systematic approach might involve creating a library of single-point mutants throughout the protein, followed by focused analysis of regions displaying functional sensitivity. Additional multiple-mutant constructs can then be created to test hypotheses about cooperative effects between residues.
Structural characterization of UPF0421 protein ygaE presents specific challenges due to its potential membrane association. A comprehensive approach includes:
Sample preparation optimization:
Screening detergents for optimal solubilization
Testing lipid nanodisc or amphipol reconstitution for native-like environment
Construct design to remove flexible regions that might impede crystallization
X-ray crystallography approach:
Vapor diffusion and lipidic cubic phase crystallization trials
Heavy atom derivatization for phase determination
Molecular replacement using predicted structures as search models
Cryo-electron microscopy:
Single-particle analysis for high-resolution structure determination
Sample vitrification optimization to ensure even particle distribution
2D classification to assess sample heterogeneity
Nuclear magnetic resonance (NMR) spectroscopy:
Selective isotopic labeling strategies for large proteins
Solid-state NMR approaches for membrane-embedded regions
Chemical shift analysis to identify secondary structure elements
Complementary techniques:
Small-angle X-ray scattering (SAXS) for solution conformation
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) for dynamics
Circular dichroism (CD) spectroscopy for secondary structure content
Understanding the evolutionary conservation of UPF0421 protein ygaE can provide crucial insights into its biological importance and function:
Comprehensive homolog identification:
Position-specific iterative BLAST (PSI-BLAST) searches against diverse bacterial genomes
Profile hidden Markov model searches using HMMER
Domain architecture analysis to identify fusion proteins or domain rearrangements
Multiple sequence alignment optimization:
Algorithm selection based on protein characteristics (e.g., MUSCLE, MAFFT, T-Coffee)
Manual refinement focusing on predicted functional regions
Incorporation of structural information when available
Phylogenetic analysis:
Maximum likelihood or Bayesian inference methods for tree construction
Bootstrap analysis to assess node confidence
Reconciliation with species trees to identify potential horizontal gene transfer events
Evolutionary rate analysis:
Calculation of site-specific evolutionary rates
Identification of positions under positive or purifying selection
Correlation of conservation patterns with structural elements
Functional site prediction:
Analysis of co-evolving residue networks
Identification of subfamily-specific conservation patterns
Integration with structural data to map conservation onto 3D structure
This evolutionary framework can guide experimental design by highlighting the most conserved, and likely functionally important, regions of the protein for targeted investigation.
Genetic manipulation studies are essential for understanding the physiological role of UPF0421 protein ygaE:
Knockout strategy selection:
Clean deletion using homologous recombination
CRISPR-Cas9 genome editing for precise modifications
Transposon mutagenesis for high-throughput screening
Antisense RNA or CRISPRi for conditional knockdown
Phenotypic characterization pipeline:
Growth curve analysis under various conditions
Stress response profiling (oxidative, osmotic, temperature)
Membrane integrity assessments
Metabolic profiling using MS or NMR approaches
Complementation construct design:
Native promoter vs. inducible expression
Chromosomal integration vs. plasmid-based expression
Inclusion of epitope tags for detection and localization
Creation of point mutant libraries for structure-function analysis
Controls and validation:
Multiple independent knockout clones to control for secondary mutations
Whole-genome sequencing to confirm clean genetic modification
RT-qPCR to verify expression levels in complementation strains
Protein detection by Western blot to confirm production
Experimental considerations:
Potential polar effects on downstream genes in operons
Compensation by paralogs or functionally redundant systems
Growth condition selection based on predicted function
A systematic approach begins with creation and validation of the knockout strain, followed by detailed phenotypic characterization, and complementation with both wild-type and mutant variants to establish specific structure-function relationships.
If UPF0421 protein ygaE functions as a membrane transporter, several specialized techniques can characterize its activity:
Membrane vesicle transport assays:
Inside-out or right-side-out vesicles prepared from cells expressing ygaE
Radiolabeled or fluorescent substrate uptake measurements
Counterflow assays to determine transport mechanism
Proteoliposome reconstitution studies:
Purified protein reconstituted into defined lipid compositions
Substrate flux measurements under controlled conditions
Establishment of kinetic parameters (Km, Vmax)
Electrophysiological approaches:
Planar lipid bilayer recordings
Patch-clamp analysis of proteoliposomes
Solid-supported membrane electrophysiology
Fluorescence-based transport assays:
pH-sensitive or ion-sensitive fluorescent probes
FRET-based substrate sensors
Single-molecule tracking of labeled substrates
In vivo transport studies:
Radiotracer uptake in whole cells
Comparison between wild-type and ΔygaE strains
Competition assays to determine substrate specificity
The selection of appropriate techniques depends on the hypothesized substrate and transport mechanism. A comprehensive approach would begin with in vivo comparisons between wild-type and knockout strains, followed by increasingly controlled in vitro systems to establish direct transport activity.
Distinguishing direct from indirect effects in ygaE mutant phenotypes requires a multi-faceted approach:
Temporal analysis of phenotypic changes:
Time-course experiments after conditional depletion
Identification of primary (rapid) versus secondary (delayed) effects
Correlation with protein half-life and turnover rate
Direct biochemical interaction testing:
Pull-down assays with potential interaction partners
Surface plasmon resonance for binding kinetics
Cross-linking coupled with mass spectrometry
Genetic approaches:
Epistasis analysis with related genes
Suppressor screens to identify genes that can compensate for ygaE loss
Synthetic lethality screens to identify functional networks
Mechanistic validation:
Point mutations that specifically disrupt hypothesized functions
Domain deletion constructs to map functional regions
Heterologous expression to test function in isolation
Systems biology integration:
Multi-omics data analysis (transcriptomics, proteomics, metabolomics)
Network analysis to place ygaE in biological pathways
Mathematical modeling to predict direct versus cascade effects
A robust experimental design includes both loss-of-function and gain-of-function approaches, coupled with molecular-level characterization of specific interactions to establish causality rather than correlation.
Post-translational modifications (PTMs) can significantly impact protein function and should be systematically investigated:
Mass spectrometry-based PTM identification:
Enrichment strategies for specific modifications (phosphopeptides, glycopeptides)
Multiple proteolytic digestions to ensure complete sequence coverage
Electron transfer dissociation (ETD) for labile modification preservation
Site-specific modification analysis:
Targeted reaction monitoring (TRM) for quantifying specific PTMs
Antibody-based detection of common modifications
Chemical labeling approaches for specific PTM types
Functional impact assessment:
Site-directed mutagenesis of modified residues
Phosphomimetic mutations (e.g., Ser to Asp/Glu)
Comparison of protein isolated under different physiological conditions
Temporal dynamics characterization:
Pulse-chase labeling coupled with immunoprecipitation
Time-resolved proteomics following stimuli
In vitro enzymatic modification/demodification assays
Modification machinery identification:
Co-immunoprecipitation with known modification enzymes
Kinase/phosphatase inhibitor screens
Bacterial two-hybrid screens with modification enzymes
This systematic approach not only identifies the presence and sites of modifications but also establishes their functional relevance in the context of ygaE's biological role.
Multi-omics integration provides a systems-level understanding of ygaE function:
Data generation and quality control:
Transcriptomics (RNA-seq) comparing wild-type and ΔygaE strains
Proteomics to identify abundance changes and interaction partners
Metabolomics to detect altered metabolic profiles
Consistent experimental design across platforms
Computational integration approaches:
Correlation network analysis across data types
Pathway enrichment analysis using databases like KEGG or BioCyc
Machine learning for pattern recognition across datasets
Bayesian network inference to establish causality
Validation experiments:
Targeted metabolite analysis for key pathways
Reporter assays for transcriptional changes
Protein-protein interaction confirmation
Flux analysis for metabolic perturbations
Contextual interpretation:
Comparison with published literature on related systems
Integration with known stress responses
Evolutionary context from comparative genomics
Environmental context from condition-specific experiments
Network visualization and analysis:
Functional module identification
Bottleneck and hub analysis
Perturbation spread modeling
Identification of compensatory mechanisms
A robust integration approach begins with quality assessment of individual datasets, progresses through computational integration, and culminates in targeted validation experiments to confirm key findings and establish mechanistic connections.
Several cutting-edge technologies show promise for elucidating the structure, function, and biological role of UPF0421 protein ygaE:
AlphaFold2 and other AI-based structural prediction tools can provide high-confidence structural models that inform experimental design even in the absence of experimental structures.
Cryo-electron tomography enables visualization of proteins in their native cellular context, potentially revealing localization patterns and interaction partners.
Single-cell technologies can uncover cell-to-cell variability in response to ygaE deletion or overexpression, revealing heterogeneous phenotypes masked in population studies.
CRISPR-based screens with single-amino acid resolution can systematically map functional regions of the protein in vivo.
Native mass spectrometry techniques are advancing for membrane proteins, allowing characterization of intact complexes with their native lipid environment.
In-cell NMR spectroscopy provides structural and dynamic information in the native cellular environment.
Integrative structural biology approaches combining multiple experimental data sources with computational modeling can overcome limitations of individual techniques.
These emerging methods, used in combination with established techniques, promise to provide unprecedented insights into the biology of UPF0421 protein ygaE.
A strategic research program for UPF0421 protein ygaE characterization should incorporate multiple approaches in a logical progression:
Gene knockout phenotyping under diverse conditions
Recombinant expression optimization and purification
Preliminary localization studies
Bioinformatic analysis and homology modeling
Biochemical activity assays based on Phase 1 insights
Interaction partner identification
Structural studies (X-ray crystallography, cryo-EM)
Site-directed mutagenesis of predicted functional residues
Detailed kinetic and thermodynamic characterization
In vivo validation of biochemical findings
Post-translational modification analysis
Reconstitution studies in defined systems
Multi-omics integration
Network analysis and pathway mapping
Evolutionary analysis across bacterial species
Physiological role determination
Potential as antimicrobial target assessment
Structural basis for inhibitor design
Biotechnological applications exploration
This phased approach ensures that each stage builds upon the findings of previous work, with multiple parallel approaches providing complementary insights at each phase.